The effectiveness of in vitro fertilization programs depending on the type of ovarian response to stimulation

The paper identifies the main groups of patients in vitro fertilization (IVF) programs. The characterization of the unexpected (paradoxical) response and its association with the polymorphism of the FSHR gene is given. A comparative characteristic of СOS protocols with the original follitropin alpha and its domestic biosimilar is presented.

The aim of the study is to increase the effectiveness of IVF programs in patients with an unexpected response by developing a differentiated approach to ovarian stimulation.

Material and methods. At the 1st stage, 920 case histories were studied; at the 2nd, 197 patients were included — a characteristic of patients with an unexpected response and its association with FSHR gene polymorphism was given; at the 3rd, an algorithm for a differentiated approach to СOS was tested in 22 patients.

Results. The main groups differ in age, efficacy, and the amount of gonadotropins. The frequency of the unexpected response was 42.8%. When comparing the original follitropin alpha and its domestic biosimilar, the effectiveness was 36.46 and 40.59% (p = 0.0511), respectively. Genotype G/A of the FSHR gene polymorphism is associated with a normal response; genotype A/A with a poor response; genotype G/G with a high response (p < 0.0001). The frequency of repeated unexpected response was 21.3%, the efficiency per cycle was 39.1% according to the results of testing the algorithm.

Conclusion. Three main groups of IVF patients have been identified to calculate the required doses of gonadotropins. An unexpected ovarian response reduces the effectiveness of IVF programs by 8.5%. Polymorphism of the FSHR gene is a significant predictor of a repeated unexpected response. The developed algorithm of the differentiated approach to the СOS makes it possible to increase the effectiveness of IVF programs.

1. Szamatowicz M., Szamatowicz J. Proven and unproven methods for diagnosis and treatment of infertility. Advances in medical sciences. 2020;65(1):93–96.

2. Korsak V.S., Smirnova A.A., Shurygina O.V. ART Register of RAHR. (In Russian)]. [Electronic resource. URL: https://www.rahr.ru/d_registr_otchet/RegistrVRT_2022.pdf

3. Zheleznyakova I.A., Volkova O.A., Fedyaev D.V., Plakhotnik O.S., Mazurov A.M., Lazareva M.L., Kotsenbina E.V. Improving the model of payment for medical care for infertility using assisted reproductive technologies in the program of state guarantees of free medical care to citizens for 2023 and 2024–2025. Medical Technologies. Assessment and Choice. 2023;(2):23–31. (In Russian). DOI: 10.17116/medtech20234502123

4. Perminova S.G. et al. The unpredictable “poor” response to ovarian stimulation in the in vitro fertilization program and the possibility of overcoming it. Obstetrics and gynecology: News. Opinions. Training. 2024;12(1)(43):6–15. (In Russian).

5. Kogan I.Yu., Gzgzyan A.M., Lesik E.A. Ovarian stimulation protocols in IVF cycles. A guide for doctors. Moscow: GEOTAR-Media, 2017:128. ISBN 978-5-9704-4321-7. (In Russian).

6. Abu-Musa A., Haahr T., Humaidan P. Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations. Int. J. Mol. Sci. 2020;21(6):2110. DOI: 10.3390/ijms21062110. PMID: 32204404; PMCID: PMC7139860.

7. Sun L., Retka S., Lejeune C., Broyles D., Manzanera K. Age stratified Anti-Mullerian hormone (AMH) reference range evaluation in polycystic ovary syndrome women at reproductive age using an automated AMH assay. Poster. 2018.

8. Alviggi C., Andersen C.Y., Buehler K., Conforti A., Placido G., Esteves S.C. et al. Poseidon Group (Patient-Oriented Strategies Encompassing Individualized Oocyte Number). A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil. Steril. 2016;105:1452–1453. DOI: 10.1016/j.fertnstert.2016.02.005

9. Chen L., Wang H., Zhou H., Bai H., Wang T., Shi W. et al. Follicular output rate and follicle-to-oocyte index of low prognosis patients according to POSEIDON criteria: a retrospective cohort study of 32,128 treatment cycles. Front. Endocrinol. (Lausanne). 2020;11:181. DOI: 0.3389/fendo.2020.00181

10. Baldini G.M., Catino A., Palini S., Sciorio R., Ferri D., Vinciguerra M., Baldini D. The Polymorphism Asn680Ser on the FSH Receptor and Abnormal Ovarian Response in Patients with Normal Values of AMH and AFC. Int. J. Mol. Sci. 2023;24:1080. DOI: 10.3390/ijms24021080

11. The possibilities of improving the effectiveness of in vitro fertilization programs in “diffi cult” patients. The attending physician. 2019;(12):14–19. (In Russian).

12. Conforti A., Tüttelmann F., Alviggi C., Behre H.M., Fischer R., Hu L. et al. Longobardi S. Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus. Front Endocrinol. (Lausanne). 2022;12:797365. DOI: 10.3389/fendo.2021.797365. PMID: 35178027.

13. Parker Gaddis K.L., Dikmen S., Null D.J., Cole J.B., Hansen P.J. Evaluation of genetic components in traits related to superovulation, in vitro fertilization, and embryo transfer in Holstein cattle. J. Dairy Sci. 2017;100(4):2877–2891. DOI: 10.3168/jds.2016-11907. Epub 2017 Jan 26. PMID: 28131573.

14. Kamilova D.P., Ovchinnikova M.M., Ablyaeva E.Sh., Leviashvili M.M., Stuleva N.S., Broitman E.V., et al. An observational study «FOLLITROPIN» comparing the effi cacy of follitropin alpha biosimilar: the real-world data. Akusherstvo, Ginekologia i Reprodukcia = Obstetrics, Gynecology and Reproduction. 2021;15(1):5–21. (In Russian)

15. Resolution of the Government of the Russian Federation dated 07/25/2024 No. 1009 “On Amendments to the Resolution of the Government of the Russian Federation dated 08/25/2014 No. 871”. (In Russian). [Electronic resource]. URL: http://publication.pravo.gov.ru/document/0001202407290030

16. Daolio J., Sperduti S., Casarini, L. et al. Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases. BMC Med Genomics. 2023;16:45. DOI: 10.1186/s12920-023-01473-3

17.